AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aspen Aerogels, Inc.

$4.91 +$2.02 (+69.90%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$4.76
Day Range
$4.75$4.99
Year Range
$2.3$9.35
Market Cap
406.93M
AVG Volume
1.45M
Trailing/Forward PE
-3.21/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0200M400M600M2016201720182019202020212022202320242025
ASPN Revenue (USD) by year
PeriodRevenue (USD)
2025271.1M
2024452.7M
2023238.72M
2022180.36M
2021121.62M
2020100.27M
2019139.38M
2018104.36M
2017111.63M
2016117.74M
Net Income (USD)
-400M-200M0200M2016201720182019202020212022202320242025
ASPN Net Income (USD) by year
PeriodNet Income (USD)
2025-389.55M
202413.38M
2023-45.81M
2022-82.74M
2021-37.09M
2020-21.81M
2019-14.56M
2018-34.44M
2017-19.32M
2016-12.02M
Operating Income (USD)
-100M-50M050M100M2016201720182019202020212022202320242025
ASPN Operating Income (USD) by year
PeriodOperating Income (USD)
2025-51.39M
202454.53M
2023-49.2M
2022-79.25M
2021-40.6M
2020-21.57M
2019-14.16M
2018-33.92M
2017-19.14M
2016-11.22M
EBITDA (USD)
-400M-300M-200M-100M0100M2016201720182019202020212022202320242025
ASPN EBITDA (USD) by year
PeriodEBITDA (USD)
2025-331.29M
202456.32M
2023-22.94M
2022-68.36M
2021-26.33M
2020-11.37M
2019-3.95M
2018-23.13M
2017-8.38M
2016-1.37M
Cash Flows (USD)
-300M-200M-100M02016201720182019202020212022202320242025
ASPN Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-4.58M
2024-40.71M
2023-218.07M
2022-272.37M
2021-32.41M
2020-13.34M
2019-3.17M
2018-12.25M
2017-10.72M
2016-13.79M
EPS (USD)
-6-4-2022016201720182019202020212022202320242025
ASPN EPS (USD) by year
PeriodEPS (USD)
2025-4.74
20240.16
2023-0.64
2022-2.27
2021-1.19
2020-0.82
2019-0.6
2018-1.44
2017-0.82
2016-0.52
Expenses (USD)
0100M200M300MR&DSG&ACapex2016201720182019202020212022202320242025
ASPN Expenses (USD) by year
PeriodExpenses (USD)
2025134.84M
2024211.11M
2023281.58M
2022262.19M
202164.31M
202039.58M
201942.55M
201842.82M
201743.92M
201647.75M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
ASPN Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025156.86M
2024220.88M
2023139.72M
2022281.33M
202176.56M
202016.5M
20193.63M
20183.33M
201710.69M
201618.09M
Debt ratios
-0.500.511.520182019202020212022202320242025
ASPN Debt ratios by year
PeriodDebt ratios
20250.04
20240.38
20230.01
20221.47
20210.95
20200.17
2019-0.13
2018-0.03
Margins
0%20%40%60%2016201720182019202020212022202320242025
ASPN Margins by year
PeriodMargins
202516.97%
202440.4%
202323.84%
20222.76%
20218.17%
202014.55%
201918.86%
201812.14%
201716.73%
201619.8%
Return on Capital
-200%-150%-100%-50%0%50%2016201720182019202020212022202320242025
ASPN Return on Capital by year
PeriodReturn on Capital
2025-165.4%
20242.18%
2023-9.39%
2022-18.49%
2021-28.89%
2020-32.14%
2019-24.69%
2018-49.02%
2017-19.14%
2016-10.4%
Shares Outstanding
025M50M75M100M2016201720182019202020212022202320242025
ASPN Shares Outstanding by year
PeriodShares Outstanding
202582.66M
202480.91M
202370.02M
202249.2M
202132.65M
202027.05M
201924.17M
201823.83M
201723.49M
201623.02M
Dividends (USD)
00.20.40.60.820062009
ASPN Dividends (USD) by year
PeriodDividends (USD)
20090.73
20060.05
Employee Count
02505007501K2016201720182019202020212022202320242025
ASPN Employee Count by year
PeriodEmployee Count
2025854
2024554
2023548
2022533
2021418
2020290
2019303
2018295
2017263
2016281
Book Value Per Share (USD)
02.557.5102016201720182019202020212022202320242025
ASPN Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20252.85
20247.6
20236.97
20229.09
20213.93
20202.51
20192.44
20182.95
20174.3
20165.02
Total Assets (USD)
0250M500M750M1B2016201720182019202020212022202320242025
ASPN Total Assets (USD) by year
PeriodTotal Assets (USD)
2025406.68M
2024895.14M
2023703.05M
2022643.42M
2021182.95M
202097.42M
2019103.5M
201899.02M
2017123.81M
2016134.67M
PE Ratio
0500100015002000med 664.6Aug 24Oct 24Nov 24Dec 24Feb 25Mar 25May 25
ASPN PE Ratio by year
PeriodPE Ratio
May 2535.27
Apr 2533.57
Apr 2531.52
Apr 2531.21
Apr 2533.09
Mar 2539.8
Mar 2542.59
Mar 2544.64
Mar 2548.09
Feb 2546.03
Feb 25410.4
Feb 25440.52
Feb 25585.48
Jan 25596.71
Jan 25588.55
Jan 25649.29
Jan 25640.1
Jan 25664.6
Dec 24636.53
Dec 24615.09
Dec 24670.73
Dec 24681.96
Nov 24755.46
Nov 24730.45
Nov 24728.92
Nov 24841.73
Nov 24990.57
Oct 241042.7
Oct 241185.39
Oct 241267.71
Oct 241453.2
Sep 241566.25
Sep 241506.98
Sep 241363.2
Sep 241304.48
Aug 241574.48
Aug 241654.06
Aug 241641.98
Aug 241199.11
Free Cash Flow Yield
-20%-10%0%10%med -0.65%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASPN Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 269.23%
Sep 269.21%
Aug 269.19%
Aug 268.74%
Aug 267.74%
Aug 267.25%
Jul 269.28%
Jul 269.2%
Jul 268.38%
Jul 268.33%
Jul 267.7%
Jun 267.63%
Jun 266.8%
Jun 267.26%
Jun 267.62%
May 266.72%
May 267.42%
May 267.68%
May 268.53%
May 26-1.3%
Apr 26-1.58%
Apr 26-1.59%
Apr 26-1.66%
Apr 26-1.5%
Mar 26-1.68%
Mar 26-1.81%
Mar 26-1.52%
Mar 261.01%
Feb 261.04%
Feb 260.9%
Feb 260.92%
Feb 260.95%
Jan 260.97%
Jan 260.85%
Jan 260.94%
Jan 260.99%
Jan 261.13%
Dec 251.11%
Dec 251.1%
Dec 251.01%
Dec 250.92%
Nov 251.01%
Nov 251.05%
Nov 251.06%
Nov 250.84%
Oct 25-0.49%
Oct 25-0.47%
Oct 25-0.51%
Oct 25-0.5%
Oct 25-0.52%
Sep 25-0.57%
Sep 25-0.59%
Sep 25-0.61%
Sep 25-0.61%
Aug 25-0.59%
Aug 25-0.57%
Aug 25-0.55%
Aug 25-0.53%
Aug 25-0.72%
Jul 25-0.7%
Jul 25-0.75%
Jul 25-0.8%
Jul 25-0.84%
Jun 25-0.93%
Jun 25-0.94%
Jun 25-0.88%
Jun 25-0.9%
May 25-0.94%
May 25-0.85%
May 25-0.86%
May 25-1.1%
May 25-8.63%
Apr 25-9.07%
Apr 25-9.66%
Apr 25-9.75%
Apr 25-9.2%
Mar 25-7.65%
Mar 25-7.15%
Mar 25-6.82%
Mar 25-6.33%
Feb 25-6.61%
Feb 25-15.04%
Feb 25-14.01%
Feb 25-10.54%
Jan 25-10.34%
Jan 25-10.49%
Jan 25-9.51%
Jan 25-9.64%
Jan 25-9.29%
Dec 24-9.7%
Dec 24-10.03%
Dec 24-9.2%
Dec 24-9.05%
Nov 24-8.17%
Nov 24-8.45%
Nov 24-8.47%
Nov 24-7.33%
Nov 24-9.58%
Oct 24-9.1%
Oct 24-8%
Price to Sales
012345med 1.42Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASPN Price to Sales by year
PeriodPrice to Sales
Sep 262.01
Sep 262.02
Aug 262.02
Aug 262.12
Aug 262.4
Aug 262.56
Jul 261.66
Jul 261.68
Jul 261.84
Jul 261.85
Jul 262.01
Jun 262.02
Jun 262.27
Jun 262.13
Jun 262.03
May 262.3
May 262.08
May 262.01
May 261.81
May 261.3
Apr 261.07
Apr 261.06
Apr 261.02
Apr 261.13
Mar 261.01
Mar 260.93
Mar 261.11
Mar 260.75
Feb 260.73
Feb 260.84
Feb 260.82
Feb 260.8
Jan 260.79
Jan 260.89
Jan 260.81
Jan 260.77
Jan 260.67
Dec 250.69
Dec 250.69
Dec 250.75
Dec 250.83
Nov 250.75
Nov 250.72
Nov 250.72
Nov 250.9
Oct 251.68
Oct 251.76
Oct 251.64
Oct 251.65
Oct 251.61
Sep 251.47
Sep 251.42
Sep 251.36
Sep 251.37
Aug 251.42
Aug 251.45
Aug 251.5
Aug 251.56
Aug 251.43
Jul 251.46
Jul 251.36
Jul 251.28
Jul 251.21
Jun 251.1
Jun 251.09
Jun 251.16
Jun 251.13
May 251.08
May 251.2
May 251.19
May 250.93
May 251.04
Apr 250.99
Apr 250.93
Apr 250.92
Apr 250.98
Mar 251.18
Mar 251.26
Mar 251.32
Mar 251.42
Feb 251.36
Feb 251.48
Feb 251.59
Feb 252.11
Jan 252.15
Jan 252.12
Jan 252.34
Jan 252.31
Jan 252.4
Dec 242.3
Dec 242.22
Dec 242.42
Dec 242.46
Nov 242.73
Nov 242.64
Nov 242.63
Nov 243.04
Nov 243.86
Oct 244.06
Oct 244.62
EV/EBITDA
0200400600med 24.06Jan 17May 24Jul 24Oct 24Dec 24Feb 25May 25
ASPN EV/EBITDA by year
PeriodEV/EBITDA
May 257.96
Apr 257.56
Apr 257.07
Apr 257
Apr 257.44
Mar 259.04
Mar 259.7
Mar 2510.19
Mar 2511
Feb 2510.52
Feb 2516.06
Feb 2517.09
Feb 2522.04
Jan 2522.42
Jan 2522.14
Jan 2524.21
Jan 2523.9
Jan 2524.74
Dec 2423.78
Dec 2423.05
Dec 2424.94
Dec 2425.33
Nov 2427.84
Nov 2426.98
Nov 2426.93
Nov 2430.78
Nov 2433.62
Oct 2435.32
Oct 2439.96
Oct 2442.64
Oct 2448.67
Sep 2452.35
Sep 2450.42
Sep 2445.74
Sep 2443.83
Aug 2452.62
Aug 2455.21
Aug 2454.81
Aug 2440.4
Aug 24289.07
Jul 24320.54
Jul 24355.43
Jul 24413.19
Jul 24360.63
Jun 24362.86
Jun 24384.09
Jun 24455.65
Jun 24457.28
May 24452.98
May 24449.27
May 24405.02
May 24409.77
May 24381.57
Feb 1712.1
Feb 1713.58
Feb 1713.54
Feb 1713.97
Jan 1714.95
Jan 1713.46
Jan 1713.11
Jan 1712.68
Dec 1612.57
Dec 1613.07
Dec 1612.84
Dec 1613.11
Dec 1612.41
Nov 1612.06
Nov 1611.83
Nov 1611.83
Nov 1612.22
Price/Operating Cashflow
0100200300med 8.78Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASPN Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 268.29
Sep 268.3
Aug 268.32
Aug 268.74
Aug 269.87
Aug 2610.55
Jul 266.24
Jul 266.29
Jul 266.91
Jul 266.96
Jul 267.52
Jun 267.59
Jun 268.52
Jun 267.98
Jun 267.6
May 268.63
May 267.8
May 267.55
May 266.79
May 2610.74
Apr 268.8
Apr 268.75
Apr 268.4
Apr 269.28
Mar 268.3
Mar 267.69
Mar 269.18
Mar 265.06
Feb 264.9
Feb 265.67
Feb 265.55
Feb 265.39
Jan 265.3
Jan 266
Jan 265.45
Jan 265.19
Jan 264.54
Dec 254.62
Dec 254.65
Dec 255.06
Dec 255.56
Nov 255.06
Nov 254.87
Nov 254.84
Nov 256.07
Oct 2511.5
Oct 2512.01
Oct 2511.22
Oct 2511.26
Oct 2510.97
Sep 2510.03
Sep 259.67
Sep 259.31
Sep 259.34
Aug 259.67
Aug 259.91
Aug 2510.24
Aug 2510.67
Aug 259.05
Jul 259.25
Jul 258.61
Jul 258.13
Jul 257.69
Jun 257
Jun 256.89
Jun 257.33
Jun 257.17
May 256.86
May 257.61
May 257.55
May 255.89
May 2510.36
Apr 259.86
Apr 259.25
Apr 259.17
Apr 259.72
Mar 2511.69
Mar 2512.51
Mar 2513.11
Mar 2514.12
Feb 2513.52
Feb 2586.53
Feb 2592.88
Feb 25123.44
Jan 25125.81
Jan 25124.09
Jan 25136.9
Jan 25134.96
Jan 25140.12
Dec 24134.2
Dec 24129.68
Dec 24141.42
Dec 24143.78
Nov 24159.28
Nov 24154.01
Nov 24153.68
Nov 24177.47
Jul 20264.87
Jul 20259.03
Jul 20271.55
Price to Book
01234med 1.76Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ASPN Price to Book by year
PeriodPrice to Book
Sep 262.11
Sep 262.12
Aug 262.12
Aug 262.23
Aug 262.52
Aug 262.69
Jul 261.79
Jul 261.81
Jul 261.99
Jul 262
Jul 262.16
Jun 262.18
Jun 262.45
Jun 262.29
Jun 262.19
May 262.48
May 262.24
May 262.17
May 261.95
May 261.5
Apr 261.23
Apr 261.22
Apr 261.17
Apr 261.3
Mar 261.16
Mar 261.07
Mar 261.28
Mar 260.87
Feb 260.84
Feb 260.97
Feb 260.95
Feb 260.92
Jan 260.91
Jan 261.03
Jan 260.94
Jan 260.89
Jan 260.78
Dec 250.79
Dec 250.8
Dec 250.87
Dec 250.95
Nov 250.87
Nov 250.84
Nov 250.83
Nov 251.04
Oct 252.17
Oct 252.26
Oct 252.11
Oct 252.12
Oct 252.07
Sep 251.89
Sep 251.82
Sep 251.75
Sep 251.76
Aug 251.82
Aug 251.87
Aug 251.93
Aug 252.01
Aug 251.98
Jul 252.03
Jul 251.88
Jul 251.78
Jul 251.68
Jun 251.53
Jun 251.51
Jun 251.61
Jun 251.57
May 251.5
May 251.67
May 251.65
May 251.29
May 250.77
Apr 250.73
Apr 250.69
Apr 250.68
Apr 250.72
Mar 250.87
Mar 250.93
Mar 250.97
Mar 251.05
Feb 251
Feb 251.21
Feb 251.3
Feb 251.72
Jan 251.76
Jan 251.73
Jan 251.91
Jan 251.88
Jan 251.96
Dec 241.87
Dec 241.81
Dec 241.97
Dec 242.01
Nov 242.22
Nov 242.15
Nov 242.15
Nov 242.48
Nov 242.66
Oct 242.8
Oct 243.18
Aspen Aerogels, Inc.
ASPN
Stockpicker

Video analysis: ASPN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ASPN

BlackRock Inc. Buys Shares of 5,277,148 Aspen Aerogels, Inc. $ASPN

defenseworld.net · 2 Sep 2026

BlackRock Inc. Buys Shares of 5,277,148 Aspen Aerogels, Inc. $ASPN

BlackRock Inc. bought a new position in Aspen Aerogels, Inc. (NYSE: ASPN) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 5,277,148 shares of the construction company's stock, valued at approximately $33,457,000. BlackRock Inc. owned 6.37% of Aspen Aerogels as of its most

Aspen Aerogels, Inc. $ASPN Shares Sold by Dimensional Fund Advisors LP

defenseworld.net · 13 Aug 2026

Aspen Aerogels, Inc. $ASPN Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lessened its position in shares of Aspen Aerogels, Inc. (NYSE: ASPN) by 37.3% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,256,480 shares of the construction company's stock after selling 747,483 shares during the quarter. Dimensional Fund

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors

seekingalpha.com · 10 Aug 2026

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors

Aspen Aerogels delivered sequential revenue and EBITDA improvement, with Q2 revenues topping guidance and Q3 outlook signaling further recovery. Thermal Barrier sales rebounded sequentially, especially in Europe, but remain pressured by regulatory shifts and evolving battery technologies. ASPN's EBITDA break-even threshold lowered to $175 million in annual revenue, reflecting cost discipline and operational progress despite fire-related disruptions.

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

seekingalpha.com · 10 Aug 2026

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

Consider the kinds of endeavors that capture our interest. My theory: They often relate to things we can see, understand and admire in day to day life. This is probably why more children aspire to be actors than, say, accountants, and why investors gravitate more to AI or fancy tech, than say, materials science.

Aspen Aerogels Q2 Earnings Call Highlights

marketbeat.com · 7 Aug 2026

Aspen Aerogels Q2 Earnings Call Highlights

Aspen Aerogels NYSE: ASPN said it expects a sharp sequential increase in revenue and adjusted EBITDA in the third quarter, supported by energy-industrial project deliveries, rising General Motors EV production and expanding European demand for its PyroThin thermal barriers.

Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript

seekingalpha.com · 6 Aug 2026

Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript

Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript

Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates

zacks.com · 6 Aug 2026

Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates

Aspen Aerogels (ASPN) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.04 per share a year ago.

Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights

globenewswire.com · 6 Aug 2026

Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Q2 2026 Thermal Barrier revenue of $29.5 million, up 81% quarter-over-quarter Q3 2026 expected revenue range of $65 to $80 million and adjusted EBITDA range of $7 to $15 million European Thermal Barrier 2026 revenue outlook raised to $20 to $30 million PyroThin® award from Jaguar Land Rover for two next-generation vehicle architectures NORTHBOROUGH, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced financial results for the second quarter of 2026, and discussed recent business developments.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.